Skip to main content
SpringerLink
Log in

Disease Management Update

  • From The World Literature
  • Published:
Disease Management & Health Outcomes

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table

Notes

  1. PharmacoEconomics & Outcomes News provides comprehensive coverage of the biomedical literature on health economics and outcomes research, and summarizes information selected from over 1600 journals.

  2. The vaccination schedule recommended three vaccine doses for infants aged 4 months, two doses for infants aged 5 to 12 months, and one dose for individuals aged 1 to 17 years.

  3. Costs (2000 values) were those related to inpatient services, outpatient follow-up, treating serogroup C disease and long-term sequelae, and the vaccination campaign. Both costs and outcomes were discounted at 3% per annum.

  4. The study was funded in part by AstraZeneca.

  5. Costs (1998 values) included those associated with primary-care and outpatient consultations, casualty visits, hospitalizations, investigations and medications prescribed for dyspepsia. Costs and benefits were discounted at a rate of 5% per annum. The study was conducted from the health service perspective.

  6. Costs of healthcare related to absolute changes in the use of hospitalization and ambulatory care.

  7. Costs (2000 values) included those associated with procedures, physician visits, and hospital services, and were calculated from a healthcare payer’s perspective.

  8. National Institute for Clinical Excellence.

  9. National Health Service.

  10. The study was funded by a grant from AstraZeneca Pharmaceuticals LP.

  11. One of the researchers was affiliated with GlaxoSmithKline.

  12. Surveillance, Epidemiology and End Results.

  13. Costs (2000 values) included skilled nursing-facility stays, physician and laboratory services, hospitalization outpatient services, home healthcare services and hospice care.

  14. Surveillance costs were based on colorectal cancer surveillance guidelines as established by the American Society of Clinical Oncology.

  15. Infliximab is only recommended in combination with methotrexate.

  16. Centers for Disease Control and Prevention.

  17. Costs (2001 values) were those related to ambulatory-care visits, emergency-department visits, hospitalization, prescription medications and other medical services.

  18. Costs were those related to inpatient and outpatient services, hepatitis A virus (HAV)

  19. Assessing Care of Vulnerable Elders.

References

1. Funding Needed for Pharmacist-Based Smoking Cessation Services

  • Pharmacists can help smokers stop so why are they not properly funded?. Pharm J 2002 Mar 9; 268: 321–2

2. Cost Main Barrier to Treatment of Osteoporosis

  • Simonelli C, Killeen K, Mehle S, et al. Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 2002 Apr; 77: 334–8

    Article  PubMed  Google Scholar 

3. Meningococcal Serogroup C Vaccination Program Well Worth it in the UK

  • Trotter CL, Edmunds WJ. Modelling cost effectiveness of meningococcal serogroup C onjugate vaccination campaign in England and Wales. BMJ 2002 Apr 6; 324: 809–12

    Article  PubMed  Google Scholar 

4. Call for US Government to Expand Support of Alternative Medicine

  • McCarthy M. US panel calls for more support of alternative medicine. Lancet 2002 Apr 6; 359: 1213

    Article  Google Scholar 

5. Guidelines for the Management of Rheumatoid Arthritis Updated

  • American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002 Feb; 46: 328–46

    Article  Google Scholar 

6. H. Pylori Screening and Treatment Program Saves Lives and Costs

  • Mason J, Axon ATR, Forman D, et al. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. Alimentary Pharm Ther 2002 Mar; 16: 559–68

    Article  CAS  Google Scholar 

7. Healthy Aging Promoted by WHO

  • World Health Organization. Healthy ageing is vital for development. Prevention of noncommunicable diseases throughout the life course is key says new WHO policy roadmap [media release]. WHO, 2002 Apr 9

8. Obesity Outranks Smoking, Alcohol Abuse in Terms of Healthcare Costs

  • Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff 2002 Mar-Apr; 21: 245–53

    Article  Google Scholar 

9. Non-Small Cell Lung Cancer: Which Diagnostic Approach is the Least Costly?

  • Harewood GC, Wiersema MJ, Edell ES, et al. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy. Mayo Clin Proc 2002 Feb; 77: 155–64

    PubMed  Google Scholar 

10. Resource Use High in Patients with Rheumatoid Arthritis

  • Girard F, Guillemin F, Novella JL, et al. Health-care use by rheumatoid arthritis patients compared with non-arthritic subjects. Rheumatology 2002 Feb; 41: 167–75

    Article  PubMed  CAS  Google Scholar 

11. Suggestions for Greater Uptake of NICE Guidance

12. Physician-Developed Guidelines for Cardiovascular Disease Released in the US

  • American Healthways. American Healthways announces publication of specialty referral guidelines for cardiac patients, 2 Apr 2002 [media release]. Available from URL: http://www.americanhealthways.com

13. Healthcare Costs in the Intensive Care Unit

  • Luce JM, Rubenfeld GD. Can health care costs be reduced by limiting intensive care at the end of life?. Am J Respir Crit Care Med 2002 May; 165: 750–4

    PubMed  Google Scholar 

14. Paving the Way for Pharmacist Prescribing in Canada

  • Task Force on Pharmacist Prescribing. An information paper on pharmacist prescribing within a health care facility. Can J Hosp Pharm 2002 Feb; 55: 56–62

    Google Scholar 

15. Public Sector—Managed Behavioral Healthcare in the US

  • Mowbray CT, Grazier KL, Holter M. Managed behavioral health care in the public sector: will it become the third shame of the states? Psychiatr Serv 2002 Feb; 53: 157–70

    Article  PubMed  Google Scholar 

16. Headache Intervention Reduces Work Days Lost, Enhances Productivity

  • Institute for Health and Productivity Management. Headache awareness and intervention program reduces work loss and enhances productivity results, reports IHPM, 26, March, 2002 [media release]. Available from URL: http://www.ihpm.org

17. Drug Discount Cards for the US

  1. NACDS offers industry-wide seniors’ Rx card. Marketletter 2002 Mar 18; 29: 13

  2. AdvancePCS offers drug discount program for all in the USA. Marketletter 2002 Mar 18; 29: 27

    Google Scholar 

18. Hospital-At-Home Care Best for Acute Exacerbations of COPD

  • Ojoo JC, Moon T, McGlone S, et al. Patients’ and carers’ preferences in two models of care for acute exacerbations of COPD: results of a randomized controlled trial. Thorax 2002 Feb; 57: 167–9

    Article  PubMed  CAS  Google Scholar 

19. Intervention Improves Lipid-Lowering Therapy in Patients with Coronary Artery Disease

  • Lacy CR, Suh D-C, Barone JA, et al. Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting. Arch Intern Med 2002 Feb 25; 162: 468–73

    Article  PubMed  Google Scholar 

20. Switch from Intravenous to Subcutaneous Epoetin Alfa and Save

  • Hynes DM, Stroupe KT, Greer JW, et al. Potential cost savings of erythropoietin administration in end-stage renal disease. Am J Med 2002 Feb 15; 112: 169–75

    Article  PubMed  Google Scholar 

21. General Practitioner Prescribing for Symptomatic Asthma Could Be Better

  • Nolan D, White P. Symptomatic asthma: attendance and prescribing in general practice. Respir Med 2002 Feb; 96: 102–9

    Article  PubMed  CAS  Google Scholar 

22. High Costs of Care for US Colorectal Cancer Survivors

  • Ramsey SD, Berry K, Etzioni R. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. Am J Gastroenterol 2002 Feb; 97: 440–5

    Article  PubMed  Google Scholar 

23. Quality of Care for Patients with Diabetes Mellitus in Rural US

  • Porterfield DS, Kinsinger L. Quality of care for uninsured patients with diabetes in a rural area. Diabetes Care 2002 Feb; 25: 319–23.

    Article  PubMed  Google Scholar 

24. Breast Cancer: Quality of Care Improves with Communication

  • Liang W, Burnett CB, Rowland JH, et al. Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol 2002 Feb 15; 20: 1008–16

    Article  PubMed  Google Scholar 

25. NICE Issues Guidance for Arthritis, Non-Hodgkin’s Lymphoma

  1. National Institute for Clinical Excellence. Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. Technology Appraisal Guidance, 2 Apr 2002 no. 35. Available from: URL: http://www.nice.org.uk

  2. National Institute for Clinical Excellence. Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. Technology Appraisal Guidance, no. 36, 2 Apr 2002. Available from: URL: http://www.nice.org.uk

  3. National Institute for Clinical Excellence. Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin’s lymphoma. Technology Appraisal Guidance, no. 37, 2 Apr 2002. Available from: URL: http://www.nice.org.uk

26. US CDC Targets Physicians to Prevent Antibacterial Resistance

  • Centers for Disease Control and Prevention. CDC promotes campaign to prevent antimicrobial resistance in healthcare settings, 26 Mar 2002 [media release]. Available from URL: http://www.cdc.gov

27. Comorbid Depression in Diabetes Mellitus: High Cost in the US

  • Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002 Mar; 25: 464–70

    Article  PubMed  Google Scholar 

28. Improving the Medication-Use System

  • Lee P. Ideal principles and characteristics of a fail-safe medication-use system. Am J Health-Syst Pharm 2002 Feb 15; 59: 369–71

    PubMed  Google Scholar 

29. Socioeconomic Factors in Health Policy: Barriers in the US

  • Syme SL, Lefkowitz B, Krimgold BK. Incorporating socioeconomic factors into U.S. health policy: addressing the barriers. Health Aff 2002 Mar-Apr; 21: 113–8

    Article  Google Scholar 

30. Optimum Use of Generics in the Elderly Could Save Billions

  • Ritter G, Thomas C, Wallack SS. Greater use of generics: a prescription for drug cost savings. Generic Pharmaceutical Association Website, 18 Apr 2002. Available from URL: http://www.gphaonline.org

31. Hepatitis A Vaccination in Hepatitis C Virus Infection Cost Effective in the US?

  • Arguedas MR, Heudebert GR, Fallon MB, et al. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. Am J Gastroenterol 2002 Mar; 97: 721–8

    Article  PubMed  Google Scholar 

32. Healthcare Expenditures to Grow Over 2001 to 2011 in the US

  • Heffler S, Smith S, Won G, et al. Health spending projections for 2001–2011: the latest outlook: faster health spending growth and a slowing economy drive the health spending projections for 2001 up sharply. Health Aff 2002 Mar-Apr; 21: 207–18

    Article  Google Scholar 

33. Improving Quality of Care in the US

  • Westropp JC. New tools address unmet need in quality assessment for older patients. Geriatrics 2002 Feb; 57: 44–51

    PubMed  Google Scholar 

34. Health and Wealth: Links to Healthcare Inequality

  • Marmot M. The influence of income on health: views of an epidemiologist: does money really matter? Or is it a marker for something else? Health Aff 2002 Mar-Apr; 21: 31–46

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Disease Management Update. Dis-Manage-Health-Outcomes 10, 385–394 (2002). https://doi.org/10.2165/00115677-200210060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200210060-00007

Search

Navigation